Enanta Pharmaceuticals (ENTA) FCF Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,840.00 |
| Dec 31, 2025 | -1,612.00 |
| Sep 30, 2025 | -5,398.00 |
| Jun 30, 2025 | 17,465.00 |
| Mar 31, 2025 | -16,187.00 |
| Dec 31, 2024 | -17,322.00 |
| Sep 30, 2024 | -16,622.00 |
| Jun 30, 2024 | -10,494.00 |
| Mar 31, 2024 | -24,940.00 |
| Dec 31, 2023 | -18,460.00 |
| Sep 30, 2023 | -16,344.00 |
| Jun 30, 2023 | -19,059.00 |
| Mar 31, 2023 | -7,104.00 |
| Dec 31, 2022 | -17,578.00 |
| Sep 30, 2022 | -15,422.00 |
| Jun 30, 2022 | -7,954.00 |
| Mar 31, 2022 | -10,305.00 |
| Dec 31, 2021 | -6,921.00 |
| Sep 30, 2021 | -10,443.00 |
| Jun 30, 2021 | -11,556.00 |
| Mar 31, 2021 | -8,907.00 |
| Dec 31, 2020 | -10,488.00 |
| Sep 30, 2020 | -3,752.00 |
| Jun 30, 2020 | 10,082.00 |
| Mar 31, 2020 | -11,765.00 |
| Dec 31, 2019 | 3,016.00 |
| Sep 30, 2019 | 22,150.00 |
| Jun 30, 2019 | -8,192.00 |
| Mar 31, 2019 | 26,964.00 |
| Dec 31, 2018 | 70,156.00 |
| Sep 30, 2018 | 24,263.00 |
| Jun 30, 2018 | 37,142.00 |
| Mar 31, 2018 | -83,017.00 |
| Dec 31, 2017 | -2,115.00 |
| Sep 30, 2017 | 17,274.00 |
| Jun 30, 2017 | 7,872.00 |